| scholarly article | Q13442814 |
| P2093 | author name string | Lan Li | |
| You-ming Li | |||
| Sheng-qi Wang | |||
| Su-hong Chen | |||
| Chao-hui Yu | |||
| P433 | issue | 2 | |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 611-620 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Journal of Proteome Research | Q3186939 |
| P1476 | title | Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray | |
| P478 | volume | 7 |
| Q93050122 | A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins |
| Q64894821 | A diagnostic autoantibody signature for primary cutaneous melanoma. |
| Q93013824 | A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins |
| Q35800748 | An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma |
| Q35680148 | An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies |
| Q35715964 | Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma |
| Q37945787 | Autoantibodies in cancer: prognostic biomarkers and immune activation |
| Q38452333 | Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma |
| Q41882566 | Chaperonin containing TCP1 subunit 5 is a tumor associated antigen of non-small cell lung cancer |
| Q54474404 | Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. |
| Q37629045 | Elevated eukaryotic elongation factor 2 expression is involved in proliferation and invasion of lung squamous cell carcinoma |
| Q37707024 | Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC. |
| Q37709461 | Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia |
| Q27305074 | Nuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype |
| Q44159554 | Prognostic utility of autoantibodies to α-enolase and Hsp70 for cancer of the gingivo-buccal complex using immunoproteomics |
| Q35170154 | Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events |
| Q37235449 | Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation. |
| Q34618992 | Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma |
| Q37977415 | Proteomic research progress in lymphatic metastases of cancers |
| Q39438407 | Secreted tumor antigens - immune biomarkers for diagnosis and therapy. |
| Q35066912 | Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterparts |
| Q37622471 | Serum autoantibodies as biomarkers for early cancer detection |
| Q34608851 | The current state of proteomics in GI oncology |
| Q38099731 | Three are better than one: plasminogen receptors as cancer theranostic targets. |
| Q24657673 | Toward unraveling the complexity of simple epithelial keratins in human disease |
| Q94570506 | Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma |
| Q37654431 | Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases. |
| Q37187763 | Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma |
Search more.